Shares of several stem-cell research companies jump following news that Swedish doctors replaced...
Shares of several stem-cell research companies jump following news that Swedish doctors replaced the cancer-stricken windpipe of a patient with an organ made in a lab: StemCells (STEM +19.9%), Geron (GERN +8.6%), Pluristem (PSTI +4.3%), Mesoblast (MBLTY.PK +3.6%), Cytori (CYTX +2.7%).
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs